CBI reported Q1 eps of $.60, five cents off of the streets estimates and revenue came in at $1.2 billion compared to street estimate of $1.27 billion. Net earnings grew 18% year over year led by growth at its project engineering and construction business. The quarter was hurt by lower than expected Steel Plate revenue and Lumus Technology income plus higher SG&A. Margins were higher than expected due to new awards in the quarter across all of their business sectors. While 85% of their work is still outside the U.S., 75% of their work from the first quarter was from North America. And with strong international position in key end-markets, there's exciting development of new energy driven infrastructure driven by shale gas and non conventional oil production presents a great oppertunity for CB&I to sustain growth well into the future. CEO Phillip Asherman said, "And so for 2012 we remain confident and the guidance we provided during our investor day in November and anticipate another solid year ahead for Chicago Birdge and Iron Company." CBI gained 1.1% despite missing earnings due to a positive outlook for the rest of the year.
-John Astarita
Thursday, May 24, 2012
Wednesday, May 23, 2012
HAL's 2012 1Q Can Be Summarized By Growth
On April 18, 2012, Haliburton (HAL) reported revenues of $6.9 billion in the first quarter (1Q) of 2012, compared to $5.3 billion in the 1Q of 2011 that represented an increase of 30.2%. Total operating profit was $1.0 billion, compared to $814 million in the 1Q of 2011. Excluding the $300 million ($191 million after-tax) charge related to the Macondo well incident, income from continuing operations in the 1Q of 2012 was $826 million, or $0.89 per diluted share. The $300 million Macondo charge is an amount that was estimated by HAL as the company anticipates this as being the future cost of the incident (this can be adjusted as new developments occur). Income from continuing operations in the 1Q of 2011 was $558 million, or $0.61 per diluted share, excluding an after-tax charge of $46 million relating to asset reservation in Libya caused by political sanctions.
Overall, all regions and most product service lines realized double-digit revenue and operating income growth from the 1Q of 2011.
· Completion and Production: Revenue in the 1Q of 2012 was $4.3 billion, a 35% increase from the 1Q of 2011. HAL reported that increased demand for pressure-pumping services in the United States and the addition of the Multi-Chem product line accounted for the majority. More specifically, cementing servicing led the way in the U.S and Latin America and all regions realized tremendous growth across this service line.
· Drilling and Evaluation: Revenue in the 1Q of 2012 was $2.6 billion, a 22% increase from the 1Q of 2011. This was primarily driven by higher drilling activity and strong demand for wireline and perforating services.
HAL experienced steady growth in unconventional oil-directed activity in the U.S. which increased by 12% and nearly countered the 17% decline in natural-gas directed rig count. The U.S continues to show strength in the oil and liquids-rich basins, while experiencing further decline in natural gas prices and related natural –gas directly activity. HAL experienced cost inflation on certain scarce materials and pricing pressure due to excess service equipment capacity in certain basins that negatively affected margins. The company expects “the transient impact of some additional natural gas rig dislocation, further cost inflation, continued pricing pressure, and the impact of spring break up in Canada to negatively impact North America’s margins by 200-250 basis points in the second quarter.
Revenue from Latin America and the Eastern Hemisphere increased by 27% and 14%, respectively. In Latin America, deep water drilling continues to lead the way, while focusing on cost structure in the Eastern hemisphere has kept HAL relatively competitive. The company expects global demand for energy to remain robust for the remainder of fiscal year 2012.
-Kelechi Nwokocha
AEO 1Q12 Earnings
American Eagle Outfitters released earnings for 1Q12 this morning, Wednesday, May 23rd. They reported net sales of $709mil compared to $603mil in 1Q11, which represents an 18% increase year-over-year. Sales were driven by a 17% increase in comparable store sales due to strong in-store traffic, a 20% increase in repeat customers, and an improved conversation rate. Revenue missed street expectations of $720mil, but an adjusted EPS of 22 cents beat the mean estimate of 20 cents per share. This marks a 40% increase in EPS year-over-year. Gross margin fell 0.1% to 37.9% mostly due to the higher cost of cotton and other products. Strong top line growth was able to take pressure off the increased cotton costs which is a good sign for the company going forward. AEO opened 7 new stores in 1Q12, and also closed 7 locations during the same period.
EPS estimate for the second quarter is between 13-15 cents which is right in line with EPS from 2Q11. For the year, adjusted EPS is expected to be $1.16 to $1.22 which assumes comp store sales growth in the low to mid single-digit range. Guidance is adjusted for the 10 cent per share 77kids operating loss due to the closing of that business. Management believes cotton costs will continue to weigh on bottom line growth until the 2nd half of 2012.
-Pete
EPS estimate for the second quarter is between 13-15 cents which is right in line with EPS from 2Q11. For the year, adjusted EPS is expected to be $1.16 to $1.22 which assumes comp store sales growth in the low to mid single-digit range. Guidance is adjusted for the 10 cent per share 77kids operating loss due to the closing of that business. Management believes cotton costs will continue to weigh on bottom line growth until the 2nd half of 2012.
-Pete
Marvell Earnings Announcement
Marvell released earnings Thursday, they reported non-GAAP EPS of 23 cents per share on revenues of $796.4 million. Street analysts were expecting EPS of 20 cents per share on revenues of $768.3 million. Marvell has also initiated a quarterly dividend of 6 cents per share, and they also are expanding their share buyback program by $500 million. Mobile and wireless end market revenue grew 14% from the year ago quarter but fell 1% from last quarter, this segment made up 29% of their total revenues. They saw an increase in their storage end market revenues of 20% from their last quarter release, resulting in a recovery from the flooding in Thailand. Gross and Operating margins dropped 4.3% and 6.7%, respectively. They still carry no long term debt and have a cash and cash equivalent balance of about $2.2 billion.
Marvell released guidance for next quarter with revenues in a range of $840-890 million, representing a sequential 6-12% increase. They also expect their mobile and wireless segment to grow between 5-10% during the next quarter, due in large part to an increase in TD smartphone revenue. Non-GAAP EPS estimates for next quarter are 28 cents per share. With the Chinese mobile market continuing to grow and China Mobile continuing their investments in the TD-SCDMA and TD-LTE networks, Marvell stands to benefit from this with a strong product line in both networks. Currently higher material costs and European exposure continue to hinder the stock lower despite a good earnings release and positive outlook.
- Ryan Ranado
Tuesday, May 22, 2012
DVA Acquires HealthCare Partners 05/21/12 - (Ryan Kennedy)
On May 21st, DaVita announced the acquisition of HealthCare Partners for $3.66 billion in cash and $758 million in stock, for a total of $4.42 billion. The acquisition of HealthCare Partners represents the entrance into a new market for DaVita, a dialysis service company. HealthCare Partners is the largest medical group and physician network in the United States, and focuses on lower medical costs and positive patients outcomes. The firm provides medical services to approximately 667,000 patients through a network of 700 physicians. HealthCare Partners operates under a capitated model, in which insurers pay a fixed amount, which encourages low-cost positive outcomes, as opposed to maximizing the volume of services and prescriptions. DaVita CEO, Kent Thiry, commented that the capitated model is "where the puck is headed for American health care." In this sense, the deal can be viewed as a way to ease the transition into a capitated dialysis market. The $4.42 billion deal values HealthCare Partners at 8.4x EBITDA, and will be funded by cash on hand and the issuance of high yield debt.
Alexion Pharmaceutical (ALXN) joins the S&P 500
Shares of Alexion Pharmaceuticals (ALXN) will replace those of Motorola Mobility Holdings (MMI) within the S&P 500 index on Friday, April 25th . MMI's departure from the index is a result of its recent takeover by Goolge. Shares of ALXN jumped 4.3%, closing at $92.54 on abnormally high trading volume.Throughout the day 5.6 million shares were traded compared to the daily average of 1.2 million shares. The stock price ranged from $91.80-$94.36, after previously closing at $91.80 the day before.
LIFE F1Q12 Earnings 4/27/12 - (Jorge Perez)
Life Technologies reported earnings on Tuesday after market hours and beat analysts’ expectations with earnings per share coming in at $0.72, up from $0.50 last Q1. Revenues increased 5% year over year to $939 million. Operating margin came in at 30.2% in the first quarter, approximately 2% higher than the same period of the prior year. This was primarily due to the company’s continued focus on operational efficiencies. They recently realigned their segments into three categories, providing historical data going back to 2010, to better reflect their business model: Research Consumables, Genetic Analysis, and Applied Sciences. Revenues increased 4%, 7%, and 4%, respectively within these segments. Genetic Analysis sales were driven by robust growth of Ion Torrent and CE products, partially offset by lower sales of SOLiD products. The change in reported earnings has no effect on results of operations, financial condition, or cash flows. Regional revenue growth rates year over year were as follows: the Americas were flat, Europe grew 2%, Asia Pacific grew 8%, and Japan grew 7%. On a negative note, their ending cash and short-term investments was down to $267 million, from $887 million in 2011, due to one-time cash payments.
The company repurchased $185 million worth in shares in the first quarter with plans to purchase another $200 million in the upcoming quarters. Their return on investment capital was 9%, while they plan to reach their goal of 10% ROIC by the end of 2012. Total debt was about $2.4 billion. In the first quarter LIFE made 2 tuck-in acquisitions with no expected material impact on earnings: Matix Microsciences and LSI. Both acquisitions will better their position in the animal health and food safety businesses. They also experienced about a 6% increase in online sales and activated more distribution centers across the world. During the quarter they continued to deliver on their innovation pipeline, launching Ion AmpliSeq Custom Panels and TaqMan Mutation Detection Assays. Looking ahead, they are still on track to release their most innovative product yet, Ion Proton, on schedule in mid and late 2012. They expect next quarter’s revenue to be flat with a tax rate of 28.6%, similar to Q1’s tax rate. Life Technologies reiterated its outlook for 2012, still expecting organic revenue growth of 2-4%, resulting in adjusted EPS of $3.90-$4.05.
-Jorge Perez
The company repurchased $185 million worth in shares in the first quarter with plans to purchase another $200 million in the upcoming quarters. Their return on investment capital was 9%, while they plan to reach their goal of 10% ROIC by the end of 2012. Total debt was about $2.4 billion. In the first quarter LIFE made 2 tuck-in acquisitions with no expected material impact on earnings: Matix Microsciences and LSI. Both acquisitions will better their position in the animal health and food safety businesses. They also experienced about a 6% increase in online sales and activated more distribution centers across the world. During the quarter they continued to deliver on their innovation pipeline, launching Ion AmpliSeq Custom Panels and TaqMan Mutation Detection Assays. Looking ahead, they are still on track to release their most innovative product yet, Ion Proton, on schedule in mid and late 2012. They expect next quarter’s revenue to be flat with a tax rate of 28.6%, similar to Q1’s tax rate. Life Technologies reiterated its outlook for 2012, still expecting organic revenue growth of 2-4%, resulting in adjusted EPS of $3.90-$4.05.
-Jorge Perez
Subscribe to:
Posts (Atom)